GlassScriptPhysician profile
Asha Kohli
NPI 1942208350
$2,151.28
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $654 · 2021: $560 · 2022: $65.40 · 2024: $32.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $471.86 | 2019-2021 | |
| Amarin Pharma, INC. | $458.21 | 2019-2021 | |
| Glaxosmithkline, LLC. | $288.14 | 2019-2021 | |
| Amgen INC. | $201.65 | 2019-2022 | |
| Novo Nordisk INC | $159.26 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $125.65 | 2019-2020 | |
| Pfizer INC. | $75.87 | 2020-2021 | |
| Eisai INC. | $49.05 | 2021-2022 | |
| Radius Health, INC. | $46.06 | 2019-2021 | |
| Exact Sciences Corporation | $32.73 | 2024 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $29.51 | 2019-2021 | |
| Abbott Laboratories | $28.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.27 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $26.83 | 2021 | |
| Dexcom, INC. | $20.38 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $18.88 | 2020 | |
| Medtronic, INC. | $18.83 | 2021 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Lilly USA, LLC | $17.17 | 2020 | |
| Bardy Diagnostics, INC. | $13.00 | 2020 | |
| Horizon Therapeutics Plc | $12.90 | 2019 | |
| Currax Pharmaceuticals LLC | $11.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asha Kohli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.